Innovative Technology Soliton’s proprietary Rapid Acoustic Pulse technology offers a non-invasive alternative to traditional laser treatments for tattoo removal and cellulite reduction, presenting an opportunity to target clinics seeking advanced equipment that enhances patient outcomes and procedure efficiency.

Market Expansion With FDA clearance in the US and ongoing investigations into additional capabilities, Soliton’s RESONIC device has the potential to expand into new aesthetic and medical markets, providing sales opportunities in clinics and medical centers focused on innovative, non-invasive treatments.

Recent Funding & Growth Having secured $9.5 million in funding and launched its flagship product, Soliton demonstrates strong growth potential, which can be leveraged in sales efforts by positioning the company as a forward-looking partner with innovative offerings in aesthetic medicine.

Industry Recognition Winning the Best New Technology Award from the Aesthetic Industry Association enhances Soliton’s credibility, creating sales opportunities by aligning with reputable recognition that appeals to clinics and practitioners interested in adopting award-winning advancements.

Acquisition and Market Traction Recent acquisitions by major pharma companies like AbbVie and Allergan suggest increasing industry interest and validation for Soliton’s technology, presenting opportunities to engage with large distributors and strategic partners looking to integrate cutting-edge aesthetic solutions into their portfolios.